![]() |
![]() |
My Amedeo
![]() ![]() ![]() |
![]() |
|||||||||
As of October 2023, Amedeo had |
Leukemia |
Free Subscription
2 Acta Haematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Fluoroquinolone Prophylaxis During Conventional Chemotherapy or Hematopoietic
Stem Cell Transplantation for Acute Leukemia - Pros and Cons.
Acta Haematol. 2023 Nov 21. doi: 10.1159/000535119.
PubMed
Abstract available
Acute febrile neutrophilic dermatosis (Sweet syndrome) in acute myeloid leukemia
patients: a 28-year institutional experience.
Acta Haematol. 2023 Nov 21. doi: 10.1159/000535399.
PubMed
Abstract available
NOTCH pathway mutation contributes to inferior prognosis in HBV-infected chronic
lymphocytic leukemia.
Ann Hematol. 2023 Nov 23. doi: 10.1007/s00277-023-05554.
PubMed
Abstract available
Research progress of additional pathogenic mutations in chronic neutrophilic
leukemia.
Ann Hematol. 2023 Nov 22. doi: 10.1007/s00277-023-05550.
PubMed
Abstract available
Allogeneic hematopoietic stem cell transplantation for pediatric acute
lymphoblastic leukemia.
Ann Hematol. 2023 Nov 22. doi: 10.1007/s00277-023-05506.
PubMed
Abstract available
Perspectives and challenges of small molecule inhibitor therapy for FLT3-mutated
acute myeloid leukemia.
Ann Hematol. 2023 Nov 17. doi: 10.1007/s00277-023-05545.
PubMed
Abstract available
Hydroquinone-selected chronic myelogenous leukemia cells are sensitive to
chloroquine-induced cytotoxicity via MCL1 suppression and glycolysis inhibition.
Biochem Pharmacol. 2023 Nov 19:115934. doi: 10.1016/j.bcp.2023.115934.
PubMed
Abstract available
Fractionated vs single-dose gemtuzumab ozogamicin with determinants of benefit in
older patients with AML: the UK NCRI AML18 trial.
Blood. 2023;142:1697-1707.
PubMed
Abstract available
Functional cure reported in CLL.
Blood. 2023;142:1761-1763.
PubMed
Acute myeloid leukemia with NUP98::HOXA9 mimicking acute promyelocytic leukemia.
Blood. 2023;142:1845.
PubMed
Wei AH, Panayiotidis P, Montesinos P, et al. Long-term follow-up of VIALE-C in
patients with untreated AML ineligible for intensive chemotherapy. Blood.
2022;140(25):2754-2756.
Blood. 2023;142:1846-1847.
PubMed
Gemtuzumab ozogamicin in AML: the next chapter.
Blood. 2023;142:1673-1674.
PubMed
Cabot rings in chronic myelomonocytic leukemia.
Blood. 2023;142:1757.
PubMed
Prevalence of symptoms in children with acute lymphoblastic leukaemia: a
systematic review and meta-analysis.
BMC Cancer. 2023;23:1113.
PubMed
Abstract available
Association of the social disorganization index with time to first septic shock
event in children with acute myeloid leukemia.
Cancer. 2023 Nov 20. doi: 10.1002/cncr.35109.
PubMed
Abstract available
Chronic myeloid leukemia (CML) in children and adolescents-Clinicopathological
findings.
Eur J Haematol. 2023 Nov 20. doi: 10.1111/ejh.14137.
PubMed
Abstract available
circ_SIRT1 upregulates ATG12 to facilitate Imatinib resistance in CML through
interacting with EIF4A3.
Gene. 2024;893:147917.
PubMed
Abstract available
Histopathological maturation in juvenile xanthogranuloma: a blueberry muffin
infant mimicking aleukemic leukemia cutis.
Int J Hematol. 2023 Nov 21. doi: 10.1007/s12185-023-03675.
PubMed
Abstract available
Prognostic significance of persisting DNMT3A, ASXL1, and TET2 mutation burden in
acute myeloid leukemia patients with allogeneic hematopoietic stem cell
transplantation during complete remission.
Leuk Lymphoma. 2023 Nov 22:1-9. doi: 10.1080/10428194.2023.2284089.
PubMed
Abstract available
Perspective on measurable residual disease testing in acute myeloid leukemia.
Leukemia. 2023 Nov 16. doi: 10.1038/s41375-023-02084.
PubMed
Thank you for your interest in scientific medicine.